Cosmo Pharmaceuticals N.V.
COPN.SW
Price:
$69.9
Market Cap:
$1.30B
Cosmo Pharmaceuticals N.V. operates as a specialized biopharmaceutical firm, primarily focused on the global development and commercialization of treatments and diagnostic tools within the gastroenterology and endoscopy fields. Its product lineup includes oral tablet formulations like Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, which are prescribed to achieve remission in cases of active, mild to moderate ulcerative colitis. The company also pioneers innovative diagnostic solutions such as GI Genius, an artificial intelligence-driven system designed to enhance the detection of colorectal polyps, and Methylene Blue MMX, a diagnostic drug that improves the visibility of pre-cancerous and ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2007-03-12
Stock Exchange
SIX
Ticker
COPN.SW
PE Ratio
[-332.86]
ROE
[-0.77%]
Current Ratio
[7.18]
Dividend Yield
[2.77%]
Enterprise Value
[1.25B]
Dividend History
COPN.SW Dividend History Overview
Dividends are a key part of long-term returns for investors, and Cosmo Pharmaceuticals N.V. (COPN.SW) has a track record worth reviewing. Looking at dividend history for COPN.SW gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2026-04-24
Dividend Yield
2.77%
Annual Dividend
$1.94
P/E Ratio
-332.86
Payout Ratio
-8.99
Dividend per Share
$2.10
EPS
-0.21
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2026-04-24 | $1.93536 | $1.93536 | 2026-05-11 | |
| 2025-06-04 | $1.24776 | $1.24776 | 2025-06-06 | |
| 2024-07-10 | $1.94713 | $1.94713 | 2024-07-12 | |
| 2023-05-31 | $1.0233 | $1.0233 | 2023-06-02 | |
| 2022-06-01 | $0.95 | $0.97652 | 2022-06-03 | |
| 2017-05-29 | $1.5 | $1.63673 | 2017-05-31 | 2017-03-24 |
Cosmo Pharmaceuticals N.V. (COPN.SW) Dividend History Chart
The table below shows Cosmo Pharmaceuticals N.V. (COPN.SW) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Cosmo Pharmaceuticals N.V. (COPN.SW) Dividend Growth
Cosmo Pharmaceuticals N.V. (COPN.SW) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Other Popular Dividend Stocks
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| SKAN Group AG (SKAN.SW) | 0.00% |
| IVF Hartmann Holding AG (VBSN.SW) | 0.03% |
| COLTENE Holding AG (CLTN.SW) | 0.04% |
| Tecan Group AG (TECN.SW) | 0.02% |
Track & Identify Dividend Stocks
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Cosmo Pharmaceuticals N.V. (COPN.SW) without the pain and hassle of copy pasting data.
Frequently asked questions❓
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is COPN.SW’s dividend yield?
What is the difference between regular and special dividends?
Has COPN.SW increased its dividends over time?
Why might dividend history data be delayed?
How often does COPN.SW pay dividends?
What factors impact COPN.SW's dividend payments?
Can dividends change over time?
What is COPN.SW’s next dividend date?